Matinas BioPharma Holdings, Inc. (MTNB)

ASE – Real Time Price. Currency in USD

0.64

+0.02 (3.15%)

At close: Jun 26, 2026, 4:00 PM EDT

0.61

-0.03 (-4.84%)

After-hours: Jun 26, 2026, 7:58 PM EDT

03.04.2026

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on April 2, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders' equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide requiring a company to have stockholders' equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years and Section 1003(a)(iii) of the Company Guide requiring a company to have stockholders' equity of at least $6.0 million if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years. As of December 31, 2025, the Company had stockholders' equity of $4.83 million and has had losses in the most recent five fiscal years ended December 31, 2025. The Notice also indicates that the Company is not currently eligible for any exemption in Section 1003(a) of the Company Guide.

Videos

No Data

There is no data to display

Press releases

03.04.2026

Matinas BioPharma Holdings, Inc. (MTNB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Videos

No Data

Press releases

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Videos

No Data

Press releases

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Search stocks

Matinas BioPharma Holdings, Inc. (MTNB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Videos

No Data

Press releases

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Videos

No Data

Press releases

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards